📰 Reneuron Group News
Page 2 - Reneuron Group News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Reneuron Group. Real-time updates on events, politics, business and more.
September 13, 2023
Octopus AIM VCT 2 plc Portfolio Update The investment portfolio of Octopus AIM VCT 2 plc as at 13 September 2023 is as follows : Portfolio companySectorBook cost Movement in valuation Fair...
September 8, 2023
The Stem Cell Therapies Market is anticipated to increase from US$ 187 million in 2021 to US$ 401 million by 2026, at a CAGR of 16.7%, by 2032.The COVID-19 pandemic has caused severe impacts on the global economy at various levels and which can be seen on the Healthcare industry as well. The thriving market of healt...
September 4, 2023
ReNeuron Group PLC (AIM:RENE, OTC:RNUGF) said it has taken an important step forward with plans to differentiate its exosome platform by generating in vivo...
September 4, 2023
UK-based biotechnology company ReNeuron Group, which specialises in stem cell-derived exosome technologies, announced significant advancements in the field of exosome research on Monday.
September 4, 2023
ReNeuron Group PLC - Brigend, Wales-based stem cell and exosomes technology company - Generates in vivo data to exemplify cellular and tissue targeting capabilities of exosomes, produced from its...
September 4, 2023
Deep Dive - ReNeuron Group PLC
August 31, 2023
Rheumatoid Arthritis Stem Cell Therapy Market | International Stem Cell Corporation, Mesoblast
August 22, 2023
RNS Announcements relating to ReNeuron Group . All announcements from sources including RNS,PRN,BZW,NLK,CCN,CIS,HUG,AFX,TNS
July 24, 2023
NOTICE OF ANNUAL GENERAL MEETING NOTICE IS HEREBY GIVEN that the annual general meeting of ReNeuron Group plc will be held at the offices of Covington &...
June 30, 2023
/PRNewswire/ -- The exosome diagnostics and therapeutics market size is set to grow by USD 483.18 million from 2022 to 2027 and register an accelerating CAGR...